United States

Nektar Therapeutics is a biopharmaceutical company that develops medicines for unmet medical needs. Its products include Bempegaldesleukin, NKTR-358, NKTR-255, and NKTR-262, which are in various stages of clinical trials for the treatment of cancer, autoimmune diseases, and COVID-19. The company has collaboration agreements with several pharmaceutical companies. Nektar Therapeutics was founded in 1990 and is based in San Francisco, California.

Nektar Therapeutics

Biopharmaceutical company developing medicines.

Google

Produkto vadovas

Duomenų mokslininkas

Nektar Therapeutics

Nektar Therapeutics Atviros pozicijos

Ar pasiruošę kelti savo karjerą? Peržiūrėkite šias atviras pozicijas Nektar Therapeutics įmonėje.